ArticleClinical drug investigation2019

Effect of Sodium Glucose Co-Transporter 2 Inhibitors on Liver Fat Mass and Body Composition in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus.

Yoshitaka Arase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.